Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366
Karine Dubé(University of California System), Eileen P. Scully(Johns Hopkins University), Catherine Godfrey(Brigham and Women's Hospital), Brandon Brown(University of California, Riverside), Jane M. Simoni(University of Cape Town), John A. Sauceda(San Francisco AIDS Foundation), Rajesh T. Gandhi(Harvard University), Kate Starr(Columbus Center), Jeremy Sugarman(Johns Hopkins University), Lara Hosey(Social and Scientific Systems (United States)), Daniel R. Kuritzkes(Brigham and Women's Hospital), David A. Wohl(University of North Carolina at Chapel Hill), Erin Hoffman(University of North Carolina at Chapel Hill), Karen Diepstra, Danielle Campbell(Delaney AIDS Research Enterprise), David Evans(Advisory Board Company (United States)), Elizabeth Barr(AIDS Clinical Trials Group)
Cited by 37
Related Papers
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|978
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|847